| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013956A2 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 03/01/2001 | WO2001013948A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 03/01/2001 | WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 03/01/2001 | WO2001013942A2 Trehalose producing prokaryotic cells as vaccines |
| 03/01/2001 | WO2001013941A1 Method for destroying, weakening and modifying micro-organisms, using high pressure |
| 03/01/2001 | WO2001013927A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 03/01/2001 | WO2001013920A1 Carnitine analogues as topical, microbicidal spermicides |
| 03/01/2001 | WO2001013913A1 Compositions containing esters for treating parasitic infestations of organisms |
| 03/01/2001 | WO2001013910A2 Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |
| 03/01/2001 | WO2001013896A1 A vaccine composition and method of using the same |
| 03/01/2001 | WO2000071146A3 Glutathione reductase for therapy and prophylaxis of aids |
| 03/01/2001 | WO2000061190A3 Treatment of intracellular infection |
| 03/01/2001 | WO2000061115A3 Pharmaceutical formulation comprising amoxycillin |
| 03/01/2001 | WO2000058270A3 Hsv primase inhibitors |
| 03/01/2001 | WO2000056361A3 Vaccine composition |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | DE19940748A1 Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide Medicament comprising xenogenic oligo- or / and polyribonucleotides |
| 03/01/2001 | DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3 |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | DE19936789A1 Neue Pyrrolidinole und ihre Verwendung für die Tumortherapie New Pyrrolidinole and their use for tumor therapy |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2384197A1 Fatty acid synthase inhibitors |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383451A1 28-epirapalogs |
| 03/01/2001 | CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382670A1 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 03/01/2001 | CA2382652A1 A vaccine composition and method of using the same |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382467A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 03/01/2001 | CA2382221A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381991A1 Synthetic human papillomavirus genes |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2376509A1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 02/28/2001 | EP1078927A1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 02/28/2001 | EP1078635A2 Medicaments comprising sialic acid derivatives as active ingredients |
| 02/28/2001 | EP1078633A2 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 02/28/2001 | EP1078092A2 Expression vectors for stimulating an immune response and methods of using the same |
| 02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078002A1 Peptide antiangiogenic drugs |
| 02/28/2001 | EP1077988A1 Crystal form 0 of clarithromycin |
| 02/28/2001 | EP1077986A2 Improvements in macrolide production |
| 02/28/2001 | EP1077984A1 2"-deoxy hygromycin derivatives |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP1077981A1 Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077977A1 Retroviral protease inhibiting compounds |
| 02/28/2001 | EP1077976A1 Water soluble azoles as broad-spectrum antifungals |
| 02/28/2001 | EP1077975A1 Water soluble azoles as broad-spectrum antifungals |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077956A1 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity |
| 02/28/2001 | EP1077949A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077722A2 Methods and products for inducing mucosal immunity |
| 02/28/2001 | EP1077719A1 Vaccine delivery system |
| 02/28/2001 | EP1077718A1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077713A1 Stable oil-in-glycerin emulsion |
| 02/28/2001 | EP1077711A2 Treatment of papilloma virus infection using a mycobacterium |
| 02/28/2001 | EP1077708A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 02/28/2001 | EP1077703A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
| 02/28/2001 | EP1077701A1 Anti-viral compounds |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP1077678A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 02/28/2001 | EP0695192B1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/28/2001 | EP0584284B1 Recombinant dna-derived cholera toxin subunit analogs |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285841A Novel erythromycin derivatives |
| 02/28/2001 | CN1285754A Monoclonal human matural antibodies |
| 02/28/2001 | CN1285753A Transdermal delivery of particulate vaccine compositions |
| 02/28/2001 | CN1285747A Combination therapy for treating AIDS |
| 02/28/2001 | CN1285746A Method and composition of an oral preparation of itraconazole |
| 02/28/2001 | CN1285745A Application of enzyme products as anti-infective agents |
| 02/28/2001 | CN1285744A Use of histamine for elevating blood histamine levels |
| 02/28/2001 | CN1285741A Double capsule for the administration of active principles in multiple therepies |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285221A Traditional Chinese injection for treating swine erysipelas and preparation process thereof |
| 02/28/2001 | CN1285207A Medicine specially for treating postpartum disease and cold syndrome |
| 02/28/2001 | CN1285203A Medicine for treating pleurisy |
| 02/28/2001 | CN1285195A Preparation for treating canine distemper and use thereof |
| 02/28/2001 | CN1285192A Process for preparation of coated azithromycin micropill |
| 02/28/2001 | CN1285191A Medicine for treating epidemic poultry and animal diseases |
| 02/28/2001 | CN1062481C Inhibitor HTV activity |
| 02/28/2001 | CN1062467C Clean-keeping agent and moisture-retaining tissue |
| 02/28/2001 | CN1062449C Method for preparation of fodder used in cultivating crustacea |
| 02/27/2001 | US6194592 As antimycotic agent |